Genprex Inc. - התחייבויות לטווח ארוך של החברה GNPX

Genprex, Inc. (GNPX) is minimally exposed to economic fluctuations, as it relies on the constant demand for advanced medicine and clinical trial results. Genprex, Inc. (GNPX) leads the way in developing gene therapy, utilizing AI-nanoparticles for drug delivery into tumors. This daily price chart illustrates the price action of Genprex, Inc. (GNPX), whose future pricing power depends on the outcome of trials, with the metric standing at 0.00.

For the biotech startup Genprex, Inc. (GNPX), which is developing a scalable cancer gene therapy platform, long-term financing is critical for completing costly research. Analyzing the company's long-term debt level, which currently stands at 0.00, an investor assesses the total volume of liabilities with maturities exceeding one year, which determines the business's degree of financial autonomy and its ability to invest in innovative drugs.